Pepper Landson Pratego, Inc.

Pepper Landson is an accomplished healthcare executive with 30 years of experience in research and development, positively impacting over 100 programs. Her contributions include products for infectious diseases, neurology, and oncology. Her tenacity fuels innovation and her talents energize successful teams. In the last decade, she has focused exclusively on developing novel therapeutics to address chronic diseases of aging.

In 2017, Pepper launched Praetego, a pharmaceutical company committed to improving health outcomes for neurodegenerative diseases. Praetego’s novel small molecules interrupt the formation of glycotoxins, specifically, Advanced Glycation End-Products (AGEs). Through Praetego she will revolutionize how we effectively limit the progression and the burden of Alzheimer’s Disease.